UnitedHealth Group Incorporated (NYSE:UNH) Stake Lessened by F M Investments LLC

F M Investments LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.6% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 75,865 shares of the healthcare conglomerate’s stock after selling 1,198 shares during the quarter. UnitedHealth Group makes up about 1.5% of F M Investments LLC’s portfolio, making the stock its 9th biggest holding. F M Investments LLC’s holdings in UnitedHealth Group were worth $44,361,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the stock. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group in the third quarter worth approximately $27,000. Global Wealth Strategies & Associates raised its position in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares during the last quarter. Macroview Investment Management LLC grew its stake in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 47 shares in the last quarter. West Financial Advisors LLC purchased a new position in UnitedHealth Group in the 3rd quarter worth approximately $32,000. Finally, Delos Wealth Advisors LLC increased its holdings in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on UNH shares. KeyCorp began coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 24th. Stephens decreased their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Finally, Bank of America lowered their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded up $3.06 on Friday, hitting $567.56. The stock had a trading volume of 2,548,368 shares, compared to its average volume of 3,259,068. The company’s 50 day moving average price is $581.96 and its 200 day moving average price is $541.50. The stock has a market cap of $524.10 billion, a price-to-earnings ratio of 36.97, a P/E/G ratio of 1.66 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $608.63.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the firm posted $6.56 earnings per share. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.48%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s payout ratio is currently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.